Category: Musculoskeletal

Lateral shoe wedging offers a simple, non-invasive approach to managing medial knee osteoarthritis (OA) by reducing load on the affected medial compartment. This biomechanical intervention has been studied extensively for its potential to alleviate pain and improve function without surgery or medication.

Biomechanics of Medial Knee OA

Medial knee OA involves cartilage degeneration primarily on the inner (medial) side of the tibiofemoral joint, often due to varus alignment where the knee angles inward. This misalignment increases medial compartment loading during weight-bearing activities like walking, exacerbating pain and joint stress.

Lateral shoe wedging counters this by tilting the foot slightly outward (into eversion), which shifts the ground reaction force laterally. A typical wedge, often 5° thick on the lateral heel or full-length sole, reduces the knee adduction moment (KAM)—a key measure of medial load—by 5-12% in responsive patients.

This unloading effect persists over time in many users, with studies showing sustained reductions in peak KAM and knee adduction angle even after one year of use.

These heel wedges, as shown, fit into everyday shoes and subtly realign the lower limb’s frontal plane mechanics to offload the medial knee.

Clinical Evidence on Pain Relief

Multiple randomized controlled trials (RCTs) support lateral wedging for symptom improvement in medial knee OA. A 2024 crossover trial of 62 patients (mean age 64) found lateral wedges reduced knee pain by 0.7 points on a 0-10 scale versus neutral insoles after 8 weeks (P=0.02), with 28% reporting meaningful pain relief.

Earlier studies confirm early benefits: a one-year trial with walking shoes and 5° wedges improved 6-minute walk test pain more than neutral orthoses, alongside gains in walk distance and stair negotiation. Another RCT (n=200) using full-length 5° wedges daily for 12 months showed modest pain reductions on numerical rating scales, though not always superior to flat insoles for all outcomes.

However, response varies—about 25% of patients show no KAM reduction, limiting efficacy in non-responders. Guidelines still recommend wedges as first-line conservative therapy due to low cost and ease.

Effects on Function and Structure

Functional gains accompany pain relief. Participants in wedge trials report better Knee Injury and Osteoarthritis Outcome Scores (KOOS), particularly in activity and quality-of-life domains, comparable to controls but with faster onset.

Structurally, evidence is mixed. While wedges reduce medial tibial cartilage stress, a major RCT found no significant difference in medial cartilage volume loss versus controls over 12 months via MRI. Bone marrow lesions and cartilage defects progressed similarly, suggesting wedges excel at symptom control rather than disease modification.

Long-term use (e.g., with custom orthoses) maintains mechanical benefits without diminishing returns, supporting adherence for sustained function.

Types of Wedges and Application

Wedging comes in heel-only or full-length forms, made from firm materials like ethyl vinyl acetate. Heel wedges (5°) are simpler but less effective than full-length versions, which better control midfoot and forefoot motion.

Podiatrists often customize wedges, combining them with orthotics for foot-specific issues like overpronation, common in knee OA patients. Patients wear them bilaterally in daily shoes, replacing every 4 months, with trimmable options for fit.

Start with neutral shoes to avoid confounding pronation effects. Compliance is key—daily use yields best results.

Patient Selection and Limitations

Ideal candidates have symptomatic medial knee OA (mild-moderate severity), varus alignment, and no significant patellofemoral OA, as lateral load shifts can worsen anterior pain.

Contraindications include lateral OA, severe foot deformities, or non-responders identified via gait analysis. Women and older adults (e.g., >60 years) predominate in studies, reflecting OA epidemiology.

Limitations: Trials show equivocal structural benefits and variable pain response (22-28% minimal improvement rates). Cost-effectiveness favors wedges over pricier options, but real-world adherence drops without monitoring.

Integration into Podiatric Practice

As a podiatrist, assess via static (varus thrust) and dynamic (gait video) exams. Fabricate in-house: full-length 5° EVA wedges under orthotic shells for arch support.

Combine with strengthening (quadriceps/hip abductors), weight loss, and NSAIDs for multimodal care. Monitor at 4-8 weeks; switch to valgus bracing if unresponsive.

The Lunge Test provides a reliable, weight-bearing measure of ankle dorsiflexion range of motion, essential for assessing functional mobility in clinical practice. Commonly known as the Weight-Bearing Lunge Test (WBLT) or Knee-to-Wall Test, it simulates real-world movements like walking or squatting. This essay explores its procedure, reliability, clinical applications, normative values, and limitations in podiatry and rehabilitation.

Test Procedure

Lunge test diagram

Perform the Lunge Test with the patient facing a wall, feet parallel and hip-width apart. Position the test foot 10 cm from the wall initially, then lunge forward by flexing the knee toward the wall while keeping the heel flat on the floor and the knee aligned over the foot. Advance or retract the foot until the knee just touches the wall at maximal dorsiflexion without heel lift.

Measure maximum toe-to-wall distance using a tape measure or ruler placed along the floor from the wall to the hallux (big toe). Alternatively, use an inclinometer on the tibia to record the angle from vertical, typically 35-38 degrees for normal function. Repeat three times per leg, averaging results, with shoes and orthotics if relevant to daily use.

This line drawing illustrates proper lunge positioning, highlighting heel contact, knee-to-wall alignment, and toe-to-wall measurement (d).​

Reliability and Validity

The WBLT demonstrates high intra-rater, inter-rater, and test-retest reliability, with intraclass correlation coefficients (ICCs) exceeding 0.92 across studies. Powden et al. (2015) found no significant differences in reliability between tape measure, inclinometer, or plumb line methods, confirming its consistency for talocrural dorsiflexion.

Concurrent validity is strong against non-weight-bearing goniometry (r=0.80-0.95), though it better captures functional restrictions from soft tissue or joint stiffness. In stroke patients, it correlates moderately with gait velocity (r=0.605), Timed Up and Go (r=-0.598), and Functional Ambulation Category (r=0.380), validating its gait relevance.

Normative Values

Normal toe-to-wall distance averages 12.5 cm (5 inches) or more, equivalent to one hand-width, indicating adequate dorsiflexion for activities like running. Tibial angle norms range 35-38 degrees; below 35 degrees signals restriction, increasing injury risk in athletes.

Values vary by population: athletes require >10 cm for lower extremity injury prevention, while <9-10 cm predicts musculoskeletal issues in sports like Australian football. In podiatry, restrictions often stem from gastrocnemius/soleus tightness or talocrural joint limitations.

Clinical Applications

Weight Bearing Lunge Test

Podiatrists use the Lunge Test to evaluate ankle dorsiflexion deficits contributing to conditions like plantar fasciitis, Achilles tendinopathy, or patellofemoral pain. Reduced range correlates with altered gait mechanics, excessive pronation, and forefoot overload, guiding orthotic prescriptions or footwear modifications.​

In rehabilitation, it tracks progress post-injury or intervention; Botulinum Toxin for spastic equinus in stroke improved median ALT from 20 mm to 21 mm (p<0.02) alongside better Timed Up and Go scores. Anterior knee pain or “pinching” during testing suggests joint capsule restrictions amenable to mobilizations, while posterior calf tightness benefits from stretching or foam rolling.

For golfers or runners—common podiatry patients—deficits heighten injury risk; serial testing informs biomechanics interventions.​​

This image shows the wall test in action, emphasizing knee drive and heel grounding for accurate assessment.​

Biomechanical Insights

Ankle dorsiflexion, primarily talocrural motion, requires 10-15 degrees for normal gait but up to 30 degrees in squatting or lunging. The WBLT measures composite stiffness including gastrocnemius, soleus, and joint arthrokinematics under load, unlike supine tests that ignore muscle tone.​

Restrictions elevate tibial shear forces, promote compensatory subtalar eversion, and strain the kinetic chain, explaining links to lower limb injuries. In evidence-based podiatry, it differentiates neural (spasticity) from musculoskeletal limits, prioritizing targeted therapies.

Limitations and Considerations

While reliable, the test assumes symmetrical foot placement and may overestimate dorsiflexion in pronated feet or underestimate in cavus deformities. It conflates talocrural and subtalar contributions, so adjunct tests like lunge with knee extended (gastrocnemius bias) enhance specificity.

Ceiling effects occur in hypermobile individuals, and floor effects in severe restrictions; inclinometry mitigates this. Perform bilaterally for asymmetry detection, and standardize with shoes/orthoses to reflect functional ROM. Patient factors like pain or balance impair performance, necessitating supervision.

Interventions Based on Results

Restricted results (<10 cm) prompt a tiered approach: soft tissue mobilization (calf stretching, foam rolling) for muscular limits, or high-velocity joint mobilizations (e.g., posterior talar glides) for capsular restrictions. Orthotics with rearfoot posting restore alignment, while minimalist footwear trains dorsiflexion in mild cases.

Reassess weekly; gains of 2-3 cm correlate with functional improvements. In pseudoscience-heavy foot care markets, emphasize WBLT’s evidence over anecdotal “barefoot resets” [user interests].​

Evidence in Podiatry Practice

Studies affirm its predictive validity: Australian footballers with lunge deficits faced higher injury rates, underscoring screening value. Powden’s review supports clinical utility across techniques, aligning with podiatric evidence-based standards.

In stroke rehab, post-Botox gains validate responsiveness. For podiatrists, it integrates into gait analysis, outperforming static measures for dynamic deficits.

Low Dye strapping is a widely used taping technique in podiatry to alleviate foot pain, particularly from conditions like plantar fasciitis. This rigid adhesive tape application supports the foot’s longitudinal arch, reduces excessive pronation, and offloads strained structures.

Origins and Technique

Low Dye Strapping

Developed by physical therapist Tom Low in the mid-20th century, Low Dye strapping targets the medial longitudinal arch to mimic ligamentous support. Clinicians apply zinc oxide or rigid sports tape in layers: starting with a figure-eight around the forefoot and heel, followed by medial and lateral strips to elevate the arch, and anchors at the metatarsals and tibia.

The process begins with skin preparation using tincture of benzoin for adhesion, then baseline strips from the plantar surface up the sides. A key lowermost strip encircles the heel and midfoot, preventing arch collapse during gait. Additional “shuttle” strips weave medially and laterally for reinforcement, typically lasting 3-7 days before reapplication.

This image shows a foot with Low Dye tape applied, highlighting the pink and blue strips stabilizing the arch and heel.

Proper technique minimizes skin irritation while maximizing biomechanical control, making it a staple in clinical settings for podiatrists treating overuse injuries.

Biomechanical Mechanism

Low Dye strapping works by limiting subtalar joint pronation, which flattens the arch and stretches the plantar fascia during weight-bearing. It acts as an external “sling,” redistributing ground reaction forces away from the heel and midfoot.

Research indicates it increases navicular height by 5-10 mm immediately post-application, reducing plantar pressure by up to 40% under the heel. This offloads the plantar fascia, Achilles tendon, and tibialis posterior, addressing pain from repetitive microtrauma.

During dynamic gait, the tape resists calcaneal eversion, promoting a more neutral foot posture. This alters kinetic chain loading, potentially easing proximal symptoms like shin splints or knee pain.

Primary Indications

Primarily indicated for plantar fasciitis, Low Dye strapping relieves heel pain from inflamed fascia insertion at the calcaneus. Patients report rapid symptom reduction, often within 48 hours, due to decreased tensile strain.

It benefits other arch-related pathologies, including posterior tibialis tendon dysfunction, where arch support counters insufficiency. Achilles tendinopathy responds as reduced pronation lessens pull on the gastro-soleal complex.

Athletes with fat pad atrophy or metatarsalgia find utility in forefoot anchoring, while golfers or runners use it prophylactically for medial overload.

Evidence from Clinical Studies

A 2005 randomized trial with 65 plantar fasciitis patients showed Low Dye taping reduced pain by 31.7 mm on a visual analog scale versus controls after 3-5 days (p<0.001). This short-term efficacy supports its diagnostic role, confirming mechanical etiology.

A 2026 meta-analysis of 11 RCTs found low-dye superior to placebo for postoperative pain (MD -1.24, 95% CI -2.39 to -0.08, p=0.04) and quality of life in plantar fasciitis, though not outperforming orthotics or sham taping long-term.

Studies affirm biomechanical changes: one measured 50% pronation reduction during stance phase, correlating with symptom relief. However, evidence quality varies, with small samples limiting generalizability.

Application Protocol

Apply to clean, dry skin after shaving hair if needed. Start supine: anchor 5cm tape at first metatarsal head, circle under foot to lateral malleolus. Repeat for heel counter.

Second layer: low dye strip from navicular, under arch to fifth metatarsal, up medial calf. Add three medial-lateral shuttles for arch lift, ending with tibial anchor. Test with toe/heel raises; trim edges.

Reapply weekly, monitoring for blisters. Combine with stretching, night splints, or orthoses for synergy.

Advantages and Limitations

Advantages include low cost (under $10 per application), non-invasiveness, and immediate effect without custom fabrication. It serves as a bridge to orthotics, aiding prognosis—if pain persists post-taping, consider alternative diagnoses like nerve entrapment.

Limitations: tape loosens with sweat (lasting 3-5 days in athletes), risks skin allergy (5-10% incidence), and lacks long-term data beyond 2 weeks. Not ideal for severe pes cavus or infection.

Compared to alternatives:

Technique	Duration	Cost	Efficacy (Pain Reduction)	Skin Risk
Low Dye Strapping	3-7 days	Low	High short-term	Moderate
Custom Orthotics	Permanent	High	High long-term	Low
Kinesio Taping	3-5 days	Low	Moderate	Low
Night Splints	Overnight	Medium	Moderate	Low

Integration in Treatment Plans

Incorporate Low Dye as first-line conservative care alongside eccentric exercises and iontophoresis. For podiatry practice, use diagnostically: 70% pain relief predicts orthotic success.

Patient education emphasizes compliance; self-application videos empower home use. Monitor progress with numeric pain scales pre/post-taping.

Future research should explore hybrid taping with elastomers for durability and RCTs versus shockwave therapy.

Potential Complications and Contraindications

Common issues: friction blisters (mitigate with Hypafix underlay), allergic dermatitis (patch test zinc oxide), or tape curl (use anchors). Remove if circulation impairs.

Contraindications: open wounds, fragile skin (diabetics stage 2+), or allergy to adhesives. Assess vascular status first.

Lisfranc fractures represent a serious midfoot injury involving disruption of the tarsometatarsal (TMT) joint complex. These injuries demand precise diagnosis and management to prevent long-term complications like chronic pain and arthritis.

Anatomy Overview

The Lisfranc joint complex spans the midfoot, linking the metatarsals (M1-M5) to the tarsals, including the medial, middle, and lateral cuneiforms plus the cuboid. Stability arises from the recessed second metatarsal base, forming a “Roman arch,” with the Lisfranc ligament anchoring the medial cuneiform to the second metatarsal base. This ligamentous and osseous architecture bears significant weight during gait, transmitting forces from the hindfoot to the forefoot.

Dorsal and plantar ligaments, along with intermetatarsal structures, reinforce the joint. The second metatarsal’s keystone position, wedged between cuneiforms, provides inherent stability, yet vulnerability persists to axial loads or twisting.

Mechanisms of Injury

High-energy trauma, such as motor vehicle accidents or falls from height, accounts for many Lisfranc fractures, often fracturing metatarsals or cuneiforms alongside dislocation. Low-energy incidents, like twisting the foot in sports (e.g., football or windsurfing), cause ligamentous sprains or subtle subluxations.

Hyperplantarflexion or direct strikes can shear the metatarsal bases, while axial loading with foot rotation disrupts the joint. In athletes, these injuries mimic ankle sprains but affect the midfoot arch. Incidence sits at about 1 in 55,000, though underdiagnosis inflates true rates.

Clinical Presentation

Patients report acute midfoot pain, swelling, and inability to bear weight, often with plantar ecchymosis across the arch—a hallmark sign from retracted dorsal vessels. Deformity may show as widened forefoot or flattened arch.

Tenderness localizes over the first or second TMT joint, worsening with pronation or passive dorsiflexion. Neuropathy can cause numbness in toes. In subtle cases, pain persists during push-off in gait, delaying recognition.

Diagnostic Imaging

Weightbearing anteroposterior (AP), lateral, and oblique radiographs reveal key signs: diastasis greater than 2 mm between the first-second metatarsal bases or “fleck” sign from avulsed Lisfranc ligament bone. Lateral views show height loss between cuneiform and metatarsal bases.journals.

Non-weightbearing films often miss instability; stress views or CT scans confirm subtle dislocations, detailing fractures and alignment. MRI excels at ligament tears, guiding surgical decisions in equivocal cases.

Classification Systems

The Hardcastle-Myles system categorizes by anatomy: Type A (total dislocation), Type B (partial, divergent or convergent), Type C (divergent with instability). Myerson refines B and C subtypes. These aid prognosis; purely ligamentous injuries fare worse than bony ones.

Quenu and Kuss predated these, but modern schemes emphasize instability over displacement

Nonoperative Management

Stable injuries without diastasis (<2 mm) or displacement suit immobilization in a non-weightbearing cast or boot for 6-8 weeks, followed by serial imaging. Partial weightbearing resumes if alignment holds, with physical therapy restoring strength and proprioception.

This approach fits extra-articular fractures or sprains confirmed stable on stress views. Success hinges on compliance; failure risks deformity.

Surgical Interventions

Unstable injuries demand operative fixation for anatomic reduction, the cornerstone of good outcomes. Open reduction internal fixation (ORIF) uses screws or plates across TMT joints, often after 10-14 days to reduce swelling.

Primary arthrodesis fuses irreparably damaged joints, especially second TMT, showing lower arthritis rates than ORIF in ligamentous cases. K-wires suffice temporarily but risk migration. Staged procedures—external fixation then ORIF—handle severe trauma.

Postoperative Care

Post-ORIF, non-weightbearing lasts 6-12 weeks in cast or boot, with screws often removed at 4 months. Therapy addresses stiffness, targeting gait normalization by 3-6 months. Full recovery spans 6-12 months, longer for athletes.

Complications like infection or hardware irritation occur in 10-20%; compartment syndrome demands vigilance.

Complications and Prognosis

Missed diagnoses lead to midfoot collapse, arthritis (up to 75% post-ORIF), and chronic pain. Post-traumatic osteoarthritis prompts salvage arthrodesis. Return to sport averages 4-6 months, with 40-80% full recovery depending on injury severity.

Risk factors include delay >6 weeks or nonanatomic reduction (>2 mm malalignment)

Rehabilitation Strategies

Phase 1 (0-6 weeks): Immobilization, elevation, edema control. Phase 2 (6-12 weeks): Protected weightbearing, range-of-motion exercises. Phase 3 (3-6 months): Strengthening, proprioception, plyometrics. Custom orthoses support the arch long-term.​

Evidence favors early intervention; athletes benefit from sport-specific protocols.

Recent Advances

Dual plating reduces hardware failure versus screws alone. Arthroscopic-assisted reduction minimizes morbidity. Biomechanical studies validate primary arthrodesis for severe injuries, cutting reoperation rates.

Research stresses weightbearing CT for instability detection.

Leg length differences in runners are common, often small, and frequently well tolerated.

Leg Length Differences in Runners

Leg length difference, also called leg length discrepancy, refers to a mismatch in the length of the lower limbs. In runners, this issue attracts attention because running is a repetitive, single-leg loading activity with little time for compensation between foot strikes. Even so, research suggests that small discrepancies are often not problematic and may be asymptomatic in many runners. The key clinical question is not simply whether a discrepancy exists, but whether it alters mechanics enough to contribute to pain, injury, or reduced performance.

A useful distinction is between structural and functional leg length difference. Structural discrepancy means the bones are actually different lengths, while functional discrepancy comes from pelvic tilt, foot posture, joint contracture, scoliosis, or other alignment factors that create the appearance of unequal legs. In practice, runners may present with either form, and the two can overlap. This matters because the treatment approach differs: a true bony discrepancy may respond to a lift or shoe modification, whereas a functional difference may improve with addressing mobility, strength, or motor control.

Biomechanically, running magnifies asymmetry more than walking. Running involves a shorter stance phase, single-limb support, and greater vertical loading, so differences between the limbs may become more apparent under impact. Experimental work suggests that even mild induced leg-length inequality can change ground reaction forces, stride length, stance time, and joint motion during running. These changes do not automatically cause injury, but they show that the body does adapt to asymmetry, often by altering loading patterns at the hip, knee, ankle, and foot.

The clinical literature does not support a simple “more difference equals more injury” rule. A classic marathon runner study found that discrepancies of 5 to 25 mm were not necessarily a functional detriment, and lifts did not show consistent benefit. In adolescent runners, leg-length inequality was not broadly associated with running-related injury, although males with a discrepancy greater than 1.5 cm had a higher likelihood of lower-leg injury. Other reports suggest that differences up to about 1 cm are common and often tolerated, while discrepancies above 2 cm are more likely to alter biomechanics and become clinically relevant. This means that magnitude matters, but symptoms and individual response matter just as much.

From a performance perspective, the effect is also nuanced. Some studies of running economy and bone length suggest that longer tibial or lower-leg proportions may be associated with better performance in certain runners, but these findings are about limb proportions rather than pathological discrepancy. That distinction is important. A naturally long or short leg is not the same as an acquired mismatch, and athletic success can occur despite asymmetry. Elite runners may compensate effectively through stride adjustments, arm swing changes, pelvic control, and long-term neuromuscular adaptation. In other words, asymmetry does not automatically mean inefficiency.

For clinicians, the main challenge is deciding when a discrepancy is clinically meaningful. Measurement method is a major issue. Tape measures, visual inspection, and even some clinical screening methods can be inaccurate, especially for small differences, while imaging is more precise for true bony length. A runner with unilateral shin pain, recurrent iliotibial band symptoms, Achilles complaints, or pelvic asymmetry may merit closer assessment than a runner with an incidental 5 mm difference and no symptoms. The best practice is to assess the whole kinetic chain rather than treating the leg length number in isolation.

Treatment should therefore be individualised. Small discrepancies often need no intervention, particularly if the runner is pain-free and training well. If symptoms appear related, a gradual trial of a lift, heel raise, or shoe modification can be reasonable, but large immediate corrections may provoke new symptoms. For functional discrepancies, mobility work, strengthening, gait retraining, and load management may be more appropriate than adding a lift. A runner’s history, training surface, footwear, speed demands, and side dominance should all shape management.

In summary, leg length differences in runners are common and often benign. Small discrepancies are usually well tolerated, while larger differences may alter biomechanics and increase the risk of certain injuries in some individuals. The most defensible clinical approach is not to chase every minor asymmetry, but to determine whether the discrepancy is structural or functional, whether it is measurable with confidence, and whether it meaningfully contributes to symptoms or loading problems. For runners, the leg length difference itself is often less important than how the body has adapted to it.world+2

The kinetic wedge is a forefoot orthotic modification designed to facilitate first ray plantarflexion and improve hallux function during gait, especially in cases of functional hallux limitus. It is used to reduce resistance to first metatarsophalangeal joint dorsiflexion and to support a more efficient windlass mechanism.

The kinetic wedge on foot orthotics

A kinetic wedge is a specific orthotic extension first described and popularised by Howard Dananberg. Its classic design places a thicker posting under metatarsals 2 to 5, with relative accommodation beneath the first metatarsal region, allowing the first ray to plantarflex more freely as load transfers forward.

The main clinical idea is simple: if the first ray is not able to plantarflex effectively, the hallux may fail to dorsiflex normally during propulsion. That can limit the windlass mechanism, alter gait progression, and contribute to compensatory loading patterns. The kinetic wedge aims to reduce that resistance by shifting plantar pressure away from the first metatarsal head and encouraging a smoother sagittal-plane transition.

Biomechanical rationale

In normal propulsion, hallux dorsiflexion tensions the plantar fascia and helps elevate the medial longitudinal arch, while the first metatarsal plantarflexes and the rearfoot can move into a more efficient position. The kinetic wedge is intended to make that sequence easier by unloading the first metatarsal head and supporting first ray motion.

This is why it is often discussed in relation to functional hallux limitus rather than rigid structural hallux limitus. In a functional restriction, the joint may appear limited under load but move more freely when mechanical conditions are improved. The kinetic wedge is one way to change those loading conditions.

Clinical applications

The kinetic wedge is most commonly used for functional hallux limitus, sagittal plane block, and windlass mechanism dysfunction. Clinically, it may be considered when the patient shows reduced first MTPJ function during stance, limited propulsion through the medial forefoot, or symptoms thought to relate to impaired first ray mechanics.

It has also been studied as a way to reduce plantar pressure under the first metatarsophalangeal joint. One study found a significant reduction in plantar pressure beneath the first MTPJ in people with moderate to severe functional hallux limitus, although it did not produce broad changes in proximal kinematics or self-reported pain over the study period.

Evidence base

The evidence suggests the kinetic wedge can change local mechanics, but its clinical effects are less consistently impressive than the theory behind it. A 2024 study found that using a kinetic wedge reduced the force required for a hallux dorsiflexion resistance test by about 39% in asymptomatic individuals, supporting the idea that it can facilitate the windlass mechanism.

However, not all outcomes improve in a straightforward way. In the Ottawa study, there were no significant increases in trunk, hip, knee, or ankle range of motion, no significant change in centre of pressure velocity, and no significant reduction in perceived pain after two months. That suggests the wedge may influence foot mechanics more reliably than it changes whole-body gait or symptoms

Practical prescription points

In practice, the kinetic wedge is usually built into a custom orthosis or a prefabricated device rather than added as a standalone modification. Its material thickness and placement matter, because the goal is to allow the first ray to move down and through loading rather than to rigidly prop the forefoot.

It should be matched to the patient’s presentation. A person with functional hallux limitus and a pronatory compensation pattern may benefit, whereas someone with rigid first MTPJ arthritis, severe structural deformity, or another dominant pain driver may not respond well. The wedge is best viewed as a targeted mechanical aid, not a universal solution.

Limitations and controversies

The kinetic wedge has a strong biomechanical narrative, but the clinical literature is still relatively small. Some studies support improved hallux function or reduced local force, while others show limited effects on pain or global gait measures.

There is also some debate about whether improving first ray plantarflexion alone is sufficient to produce durable symptom relief. In real patients, footwear, calf flexibility, first MTPJ joint integrity, load tolerance, and activity demands all interact with orthotic design. For that reason, the kinetic wedge is often most useful when it is part of a broader treatment plan.

The kinetic wedge is a focused orthotic modification used to facilitate first ray plantarflexion and improve hallux dorsiflexion during gait. Its main value lies in functional hallux limitus and related sagittal plane dysfunction, where it can reduce pressure beneath the first metatarsal head and help restore a more efficient windlass mechanism

Overall, the kinetic wedge is a plausible and clinically useful device, but it should not be oversold. Current evidence supports changes in local mechanics more clearly than it supports large, consistent improvements in pain or whole-limb gait variables. In practice, its success depends on correct patient selection, sound orthotic design, and integration with the broader biomechanical context.

Joplin’s neuroma is a rare painful nerve condition of the foot, usually affecting the medial plantar digital proper nerve to the big toe. It is commonly associated with bunion deformity or prior bunion surgery, and it can cause burning, tingling, numbness, and focal pain along the inner side of the hallux.

Joplin’s Neuroma in the Foot

Joplin’s neuroma is an uncommon neuropathic pain syndrome involving the medial proper digital nerve of the hallux, the nerve that supplies sensation to the inner side of the big toe. It is not a true tumor in the usual sense; rather, it is a fibrotic, irritated, and painful thickening of the nerve that develops after repeated compression or injury. In clinical practice, it is much less frequently discussed than Morton’s neuroma, but it can be equally disabling for the patient because it interferes with walking, footwear tolerance, and daily activity.pure.

The condition is especially relevant in people with hallux valgus, bunion deformity, or a history of bunion surgery. These situations can alter the mechanics of the forefoot and place traction or compression on the medial digital nerve, leading to chronic irritation. Repetitive pressure from footwear, deformity-related friction, and prior surgical scarring are all thought to contribute to the nerve’s pathological changes.

Pathology

The term “neuroma” can be misleading because Joplin’s neuroma is more accurately described as a perineurial fibrosis or traumatic neuritis rather than a neoplastic growth. The nerve becomes thickened and hypersensitive after ongoing mechanical stress. This differs from the better-known Morton’s neuroma, which more often affects the intermetatarsal spaces of the forefoot, usually between the third and fourth toes. Joplin’s neuroma is located on the medial side of the great toe, so its pain pattern is more localized to the inner hallux rather than the ball of the foot.

The pathology likely reflects chronic nerve compression and irritation rather than a single acute event. Over time, the nerve’s normal architecture is disrupted, and the patient experiences pain from both nerve inflammation and altered signal transmission. Because nerves are highly sensitive structures, even modest mechanical disturbance can produce significant symptoms.

Clinical Features

Patients typically describe pain along the medial aspect of the big toe, often with burning, tingling, numbness, or hypersensitivity to touch. The pain may worsen with shoes that press on the bunion region or with walking and prolonged standing. Some patients notice tenderness to palpation along the course of the nerve, while others report symptoms that are more intermittent and provoked by activity or certain footwear.

Unlike joint pain from hallux valgus itself, Joplin’s neuroma pain has a neuropathic character. It may feel sharp, electric, or radiating, and it can be out of proportion to visible structural findings. The symptoms can overlap with postoperative scar pain, localized neuritis, or other forefoot disorders, which is one reason diagnosis is often delayed.pure.

Diagnosis

Diagnosis is primarily clinical and rests on a careful history and examination. A clinician should ask about bunion deformity, prior bunion surgery, shoe-related aggravation, sensory symptoms, and any prior trauma to the forefoot. Focal tenderness over the medial plantar digital nerve to the hallux supports the diagnosis, especially when symptoms are reproducible with local pressure.

Imaging is often used to exclude other causes of great toe pain rather than to definitively confirm Joplin’s neuroma. Ultrasound or other imaging may help rule out alternative pathology, but the condition is usually recognized by its characteristic symptom pattern and location. As with other foot neuromas, the absence of a bony abnormality does not exclude a nerve problem, so clinical suspicion remains essential.

Conservative Treatment

Initial treatment is nonoperative. The first goal is to reduce mechanical irritation of the nerve. Wider footwear, softer uppers, avoidance of tight toe boxes, and offloading pads can make a major difference. Activity modification, icing, and anti-inflammatory medications may also provide relief, especially early in the course of the disorder.neurosurgery.

When symptoms persist, clinicians may consider medications aimed at neuropathic pain or corticosteroid injections in selected cases. The logic behind injection therapy is to reduce local inflammation and pressure around the irritated nerve. Although evidence is stronger for Morton’s neuroma than for Joplin’s neuroma specifically, the same principle is often applied in practice because the underlying pain mechanism is similar.neurosurgery.

Surgery

Surgery is generally reserved for patients who fail prolonged conservative treatment. In a small series, surgical resection of the affected medial digital nerve with implantation of the proximal stump into the arch of the foot produced good to excellent results in most patients, with about 80 percent reporting good-to-excellent pain relief. This suggests that carefully selected patients can benefit substantially when nonoperative care fails.pure.

The operative strategy aims to remove the painful segment, prevent recurrent neuroma formation, and reduce traction on the nerve stump. As with many peripheral nerve procedures, outcomes depend on the accuracy of diagnosis, the severity of preoperative nerve damage, and the presence of associated deformity such as bunion alignment problems.

Prognosis

The prognosis is usually favorable when the condition is recognized early and the mechanical cause is addressed. Many patients improve with footwear modification and offloading alone, especially if symptoms are mild or of short duration. Chronic cases, particularly those related to prior surgery or significant deformity, may require more aggressive treatment and can be harder to resolve completely.

Long-term outcomes depend on whether the nerve irritation can be stopped. If the bunion deformity or shoe pressure persists, the symptoms may recur even after temporary improvement. For that reason, treatment often needs to address both the nerve pain and the underlying biomechanical driver.

Joplin’s neuroma is a rare but important cause of medial big-toe pain. It is best understood as a painful fibrotic irritation of the medial plantar digital nerve, often linked to bunion deformity or bunion surgery. Recognition of its neuropathic symptom pattern is crucial because treatment is usually effective once the nerve is properly offloaded or, in refractory cases, surgically addressed.pure.

Jones Fracture in the Foot

A Jones fracture is a break in the fifth metatarsal, the long bone on the outer side of the foot that connects to the little toe. It is important because it occurs in a part of the bone with relatively limited blood supply, which makes healing slower and increases the risk of nonunion compared with many other foot fractures.

A Jones fracture usually follows a twisting injury, sudden impact, or repetitive stress to the outside of the foot. It is commonly seen in athletes, dancers, runners, and anyone who places repeated load through the lateral foot, especially during cutting, jumping, or pivoting movements.

Anatomy and Definition

The fifth metatarsal is divided into zones, and a true Jones fracture occurs in Zone 2, near the junction between the base and shaft of the bone. This is distinct from a tuberosity avulsion fracture at the base of the bone, which is sometimes called a pseudo-Jones fracture and generally heals more reliabl

The reason this fracture matters clinically is that the Zone 2 region lies in a vascular watershed area, where blood flow is comparatively poor. That reduced circulation helps explain why healing can be delayed and why some fractures fail to unite without more aggressive treatment.

Causes and Risk Factors

Jones fractures usually happen after the foot is forced into a twisted position while weight-bearing. Common mechanisms include sports injuries, sudden changes in direction, landing awkwardly from a jump, or stumbling on uneven ground.

Repetitive overuse can also contribute, especially in people who run or stand for long periods on hard surfaces. In some cases, foot alignment, high training loads, or a previous fracture may increase risk, although the exact contributor varies from person to person.

Symptoms

Typical symptoms include pain on the outer side of the foot, swelling, tenderness over the fifth metatarsal, and difficulty walking or bearing weight. Some people can still walk after the injury, but pain usually worsens with push-off, turning, or activity.

Bruising may appear, and the area is often painful to touch. Because symptoms can overlap with other lateral foot injuries, clinical assessment and imaging are usually needed to confirm the diagnosis.

Diagnosis

Diagnosis is usually made with a physical examination and an X-ray. The clinician looks for point tenderness over the fifth metatarsal and correlates that with imaging findings to identify the fracture location and pattern.

Correct classification is important because a Zone 2 Jones fracture has a different prognosis from other fifth metatarsal fractures. That distinction helps guide treatment and gives a better estimate of the expected recovery time.

Treatment

Treatment depends on the fracture pattern, degree of displacement, activity level, and patient goals. Initial care often includes rest, immobilization in a boot or cast, ice, elevation, pain control, and limiting weight-bearing to reduce stress across the fracture site.

Many Jones fractures, especially in active patients or athletes, are treated surgically because surgery can improve union rates and allow a more predictable recovery. Non-surgical treatment is possible in selected cases, but it often requires strict protection and close follow-up because delayed union and nonunion are more common than with many other fractures.

Recovery and Healing

Healing time varies, but many sources describe recovery as taking roughly three to four months, and sometimes longer if complications occur. Some patients may need six to eight weeks of immobilization first, followed by gradual progression back to weight-bearing and activity.

Return to sport or strenuous activity should be slow and guided by symptoms and clinical review. If the fracture does not heal as expected, or if pain persists, further treatment such as surgery or bone grafting may be needed.

Complications

The most important complications are delayed union, nonunion, and refracture. These problems are more likely in Jones fractures because of the limited blood supply in the fracture zone and the mechanical forces acting through the lateral foot during walking and sport.

Other complications may include prolonged pain, stiffness after immobilization, weakness of the surrounding muscles, and time away from work or sport. These issues highlight why early diagnosis and appropriate management are so important.

Clinical Importance

For clinicians, the Jones fracture is a classic injury because it sits at the intersection of biomechanics, vascular anatomy, and load management. It is not simply a “small foot fracture”; it is a fracture with meaningful implications for healing time, rehabilitation, and return to function.

For patients, the key message is that persistent pain on the outside of the foot after a twisting injury should not be ignored. Early assessment can prevent delayed treatment and reduce the chance of long-term problems.

A Jones fracture is a fracture of the fifth metatarsal in a high-risk healing zone of the foot. Because it has a greater chance of delayed healing than many other fractures, accurate diagnosis, proper immobilization, and careful follow-up are essential.

Heel fat pad atrophy is an increasingly recognised cause of plantar heel pain, especially in older or high‑impact populations, and is frequently misdiagnosed as plantar fasciopathy. It involves structural and functional failure of the calcaneal fat pad, resulting in reduced shock absorption, focal overloading of the calcaneus, and characteristic bruised, central heel pain with weightbearing.

Anatomy and biomechanics of the heel fat pad

The plantar calcaneal fat pad (corpus adiposum) is a specialised fibro‑adipose structure that overlies the inferior surface of the calcaneus. It is organised into elastic fat chambers separated by fibrous septa that anchor to the periosteum, designed to resist shear and dissipate vertical ground reaction forces during gait. In a healthy adult, heel pad thickness is typically around 1–2 cm, with ultrasound studies reporting unloaded thickness close to 18–20 mm and significant but controlled compressibility under load. During walking, the heel can be exposed to forces of approximately 110% of body weight, rising to around 200% during running, which the fat pad normally attenuates. This mechanical role explains why subtle structural change can produce disproportionate symptoms.

Pathophysiology and aetiology

Heel fat pad atrophy reflects thinning, fragmentation, or displacement of the corpus adiposum accompanied by loss of elasticity and hydration. Micromechanical failure of the fibrous septa is thought to reduce structural integrity, impairing shock absorption and allowing higher peak plantar pressures directly over the calcaneus. Over time, repetitive high‑impact loading, such as running or jumping, and prolonged standing on hard surfaces drive cumulative microtrauma and wear, particularly when combined with inadequate footwear or barefoot loading on rigid substrates.

Multiple intrinsic and extrinsic factors contribute. Ageing leads to reduced collagen elasticity, loss of soft‑tissue moisture, and thinning or displacement of the fat pad, making heel fat pad syndrome more prevalent in older adults. Biomechanical factors, including altered arch alignment, high arches, and abnormal gait patterns, shift load toward the posterior calcaneus and increase local stress. A history of corticosteroid injection into or near the heel has been associated with fat pad breakdown, presumably via catabolic effects on collagen and adipose tissue. Systemic factors such as obesity and certain medical conditions further compromise tissue integrity and may accelerate thinning. Less commonly, acute trauma or a single episode of excessive heel strike can precipitate symptomatic structural failure.

Clinical presentation and differential diagnosis

Clinically, patients typically describe a deep, dull, “bruised” pain centred under the heel that is provoked by weightbearing and worsens on hard surfaces or when walking barefoot. Standing or walking for prolonged periods aggravates symptoms, whereas non‑weightbearing usually provides rapid relief. On examination, there is focal tenderness beneath the posterior‑central calcaneus, often slightly lateral to the midline, corresponding to the main weightbearing point at heel strike. The pad may feel thinned or less resilient on palpation compared to the contralateral side, and compressive testing may reproduce pain.

Differentiating heel fat pad atrophy from plantar fasciopathy is clinically important, as management priorities differ. Plantar fasciitis usually presents with medial calcaneal and proximal fascial tenderness and pronounced “first‑step” pain after rest, whereas fat pad pain is more central/posterior, often maximal during prolonged standing or impact and particularly severe when barefoot on firm ground. Radiology and ultrasound can assist: imaging in heel fat pad syndrome may demonstrate reduced fat pad thickness, altered echotexture, septal defects, fibrosis, or oedema within or around the pad, whereas plantar fasciopathy shows fascial thickening and entheseal changes. A scoping review suggests heel fat pad syndrome may be the second most common cause of plantar heel pain, yet is frequently overlooked or conflated with plantar fasciopathy in the literature and in practice.

Investigations

Although heel fat pad atrophy is primarily a clinical diagnosis, imaging can provide objective corroboration and help exclude other pathology. Ultrasound offers a practical method to quantify heel pad thickness in unloaded and loaded states and to assess compressibility, with studies reporting abnormal thinning and altered compressibility indices in symptomatic patients. MRI can demonstrate changes such as focal atrophy, fibrosis, oedema, and septal defects, alongside assessment of surrounding soft tissues and bone marrow. Radiographs may be useful to assess calcaneal spurs or other bony pathology but are less informative regarding fat pad quality. Objective measurement can be valuable in tracking progression and response to interventions in both clinical and research settings.

Conservative management

Management is initially conservative and centres on reducing peak plantar pressures while optimising overall foot biomechanics. Activity modification is foundational: patients are advised to reduce or temporarily cease high‑impact activities such as distance running and court sports, substituting with lower‑impact exercise where possible. Footwear education is crucial, emphasising supportive shoes with firm heel counters, appropriate arch support, and adequate heel cushioning; walking barefoot or in thin‑soled footwear on hard surfaces is discouraged. External devices—including cushioned socks, silicone or gel heel cups, and custom or semi‑custom insoles—aim to increase cushioning and, importantly, to contain and centralise the fat pad under the calcaneus.

Clinical taping techniques can be used to “cup” and reposition the pad beneath the heel, providing symptomatic relief and serving as a predictor of orthotic response. Physiotherapy or podiatry‑led rehabilitation often includes strengthening of intrinsic and extrinsic foot and ankle musculature, improving load sharing and dynamic stability, as well as targeted mobilisation of the rearfoot, talocrural joint, and plantar fascia to restore normal motion patterns. Adjunctive measures, such as short periods of icing and judicious use of oral or topical non‑steroidal anti‑inflammatories, may assist during acute exacerbations, although they do not address the underlying structural deficit. Importantly, repeated corticosteroid injection into the heel should be avoided in this population because of its association with further fat pad compromise.

Emerging interventional approaches and evidence gaps

For patients who remain significantly symptomatic despite optimised conservative care, several interventional strategies have been explored, though the evidence base remains limited. These include injectable fillers and heel fat pad augmentation via autologous fat grafting, which aim to restore volume and shock‑absorbing capacity. Clinical trial protocols investigating autologous fat transfer suggest that improving plantar cushioning may reduce peak plantar pressures, potentially lowering the risk of ulceration in high‑risk groups such as individuals with diabetes and bony prominence. Early case series and small studies report imaging‑confirmed changes in fat pad morphology, including atrophy, fibrosis, and oedema, but there remains a “glaring absence” of robust controlled trials evaluating the long‑term efficacy and durability of commonly used conservative and surgical interventions.

Consequently, current best practice emphasises accurate diagnosis, comprehensive mechanical off‑loading, and optimisation of global foot function, while recognising that definitive regenerative solutions are still under investigation. From a clinical perspective, heel fat pad atrophy underscores the importance of viewing plantar heel pain as a heterogeneous symptom complex rather than a monolithic “plantar fasciitis” entity, demanding careful localisation of pain, biomechanical assessment, and tailored intervention.

Rigid carbon plates are a key non‑operative option for reducing first metatarsophalangeal joint (1st MTPJ) pain and improving function in patients with hallux rigidus by limiting painful dorsiflexion while preserving overall gait efficiency. Their use is supported by clinical studies on rigid and carbon‑based insoles, as well as growing clinical experience and commercial device design focused on targeted forefoot motion control.

Pathophysiology of hallux rigidus

Hallux rigidus is a degenerative arthropathy of the 1st MTPJ characterised by progressive cartilage loss, dorsal osteophyte formation, and reduced sagittal plane range of motion, particularly dorsiflexion. The loss of joint congruency and osteophyte impingement elevates joint reaction forces during propulsion, producing pain, stiffness, and altered push‑off mechanics.

As dorsiflexion becomes limited and painful, patients commonly compensate by externally rotating the foot, transferring load laterally to lesser metatarsal heads, or shortening step length, which can lead to secondary metatarsalgia, midfoot overload, and reduced walking speed. Conservative interventions therefore aim to reduce painful dorsiflexion moments at the 1st MTPJ while maintaining sufficient forefoot stability for efficient gait

Rationale for rigid carbon plates

Rigid orthoses have long been used to “splint” the first ray and limit 1st MTPJ motion as a primary strategy in conservative management of hallux rigidus. A systematic review of non‑operative care reports that footwear modifications and rigid custom insoles are effective in roughly half of patients, supporting their role as first‑line therapy.

Carbon fibre is particularly suited to this task because it offers very high stiffness at minimal thickness and weight, allowing substantial motion restriction with relatively low bulk. By stiffening the forefoot region of the shoe, carbon plates reduce bending at the ball of the foot so that the big toe joint does not need to dorsiflex as much during terminal stance, thereby decreasing joint loading and pain.

Design characteristics of carbon plates

Rigid carbon plates for hallux rigidus are usually thin (around 1.0–1.2 mm) and flat or slightly contoured, with minimal flex across the metatarsal heads. Their stiffness is achieved using high‑strength carbon (often combined with glass fibres) embedded in a polymer matrix, producing a durable, fatigue‑resistant structure that tolerates repetitive forefoot loading.

Two main geometries are commonly employed:

• Morton’s extension plates: extend under the hallux and first metatarsal, allowing more normal motion of the lateral metatarsophalangeal joints while specifically splinting the first ray.carboneaze+1
• Full‑width forefoot plates: span the entire forefoot, limiting motion at both the 1st MTPJ and lesser MTPJs and creating a more global rocker effect.

Choice of design is typically dictated by whether isolated first‑ray control is desired or whether broader forefoot immobilisation and rocker function are clinically advantageous.

Clinical evidence for carbon‑based insoles

Although many traditional devices used polypropylene or other rigid plastics, carbon fibre has increasingly been adopted as a base material for rigid 1st ray splinting orthoses. A randomized controlled trial comparing flexible carbon fibre insoles with a rigid Morton’s extension in patients with unilateral 1st MTPJ arthritis found that flexible carbon insoles produced significantly greater reductions in pain interference and pain intensity scores at 6 and 12 weeks, with higher comfort and better compliance.

Specifically, the flexible carbon group demonstrated larger median improvements in PROMIS pain interference and pain intensity scales, while the more rigid Morton’s extension did not achieve similar gains despite also restricting motion. The authors concluded that carbon‑based insoles which balance mechanical shielding with some preserved motion may provide superior symptom relief and patient adherence compared with very rigid orthoses.

Beyond this trial, a broader review of conservative hallux rigidus care notes that custom insoles fabricated from rigid materials, including carbon fibre, reduce symptoms in a substantial proportion of patients and carry a moderate level of evidence within an evidence‑based framework. Emerging work in related forefoot and midfoot pathologies also suggests that full‑length carbon insoles can reduce forefoot loading and alter muscle activation patterns in ways that may support pain reduction and gait efficiency.

Mechanisms of symptom relief

Rigid carbon plates treat hallux rigidus primarily through mechanical modification of the 1st MTPJ environment:

• Motion restriction: By limiting dorsiflexion at the 1st MTPJ, plates decrease peak articular cartilage stress and dorsal osteophyte impingement during propulsion.
• Load redistribution: The stiffened forefoot encourages a more rocker‑like gait, shifting load proximally and to adjacent structures rather than concentrating it at the arthritic joint.
• Capsular protection: In conditions such as turf toe and big‑toe arthritis, carbon plates protect the joint capsule from excessive dorsiflexion and repetitive microtrauma.

These mechanical effects collectively reduce pain, dampen inflammatory flares, and may slow progression of degenerative change by limiting repeated high‑stress motion at the affected joint.

Integration with footwear and orthoses

Successful use of rigid carbon plates depends heavily on shoe compatibility and integration with existing orthotic therapy. Many clinicians either place the plate directly under the insole in a suitable shoe, or incorporate it into a custom device to avoid excess bulk and maintain foot position control. Full‑length plates often work best in footwear with adequate depth and a relatively stiff outsole, further enhancing the rocker function created by the plate.

Layering a carbon plate beneath a functional orthotic can be particularly useful in hallux rigidus, with the plate restricting painful toe motion while the orthosis addresses rearfoot and midfoot mechanics and redistributes plantar pressures. However, excessive stack height from combining OTC inserts with separate plates can compromise fit and comfort, so careful device selection and shoe testing are important.

Advantages and limitations

Rigid carbon plates offer several practical advantages in managing hallux rigidus:

• High stiffness with low profile and weight, improving shoe fit compared with many traditional rigid insoles.
• Reversible, non‑invasive intervention compatible with other conservative measures such as NSAIDs, intra‑articular injections, and physiotherapy.
• Versatility in design (Morton’s extension vs full‑width) to tailor motion restriction to the individual’s pathology and activity demands.

Conversely, limitations include potential discomfort from excessive rigidity, difficulty fitting plates into fashion or low‑volume footwear, and patient reluctance to accept changes in shoe feel or forefoot rocker mechanics. Over‑restriction of forefoot motion may transfer stress to proximal joints or lesser MTPJs, and plates may not adequately control pain in advanced cases where surgical options such as cheilectomy, arthrodesis, or arthroplasty are more appropriate.

Place in overall management

Within the broader conservative algorithm for hallux rigidus—alongside pharmacologic therapy, intra‑articular injections, activity modification, and footwear changes—rigid carbon plates occupy a central role as a mechanical pain‑relief strategy that can delay or obviate surgery for many patients. Evidence indicates that about half of patients achieve meaningful symptom control with such conservative measures, justifying early and systematic use of these devices.

Contemporary research comparing rigid Morton’s extensions with flexible carbon fibre insoles suggests that optimal plate design for hallux rigidus may require a nuanced balance between sufficient rigidity to shield the joint and enough flexibility to preserve comfort and normal mechanics. For clinicians and patients, rigid and semi‑rigid carbon plates therefore represent a valuable, adaptable tool in the non‑operative management of hallux rigidus, particularly when carefully matched to footwear, orthotic strategy, and the individual’s functional goals.